Suggested Topics within your search.
Showing 161 - 180 results of 771 for search '"programmed cell death protein 1"', query time: 5.56s Refine Results
  1. 161
    Pulmonary sarcomatoid carcinoma: progress, treatment and expectations
    by Xin Li, Di Wu, Hongyu Liu, Jun Chen
    Published 2020-08-01
    “... immunity via pathways including programmed cell-death protein-1/programmed cell-death ligand-1 ( PD-1/PD-L1...”
    Get full text
    Article
  2. 162
    Recent updates on Sintilimab in solid tumor immunotherapy
    by Xuhong Liu, Yong Yi
    Published 2020-12-01
    “... the binding site of programmed cell death protein 1 (PD-1), thereby, inhibiting the interaction between PD-1...”
    Get full text
    Article
  3. 163
    PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models
    “... the different variations of cancer immunotherapy, the checkpoint inhibitors targeting the programmed cell death...”
    Get full text
    Article
  4. 164
    Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection
    “... associated antigen 4 and programmed cell death protein 1, have been shown to induce durable complete...”
    Get full text
    Article
  5. 165
    Molecular Modeling Studies on the Binding Mode of the PD-1/PD-L1 Complex Inhibitors
    by Suliman Almahmoud, Haizhen A. Zhong
    Published 2019-09-01
    “...The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) is an immune...”
    Get full text
    Article
  6. 166
    Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis
    “...A 71-year-old Japanese woman was treated with programmed cell death protein-1 (PD-1) inhibitor...”
    Get full text
    Article
  7. 167
    NK Cell-Fc Receptors Advance Tumor Immunotherapy
    by Emilio Sanseviero
    Published 2019-10-01
    “... approaches, antibodies targeting immune checkpoint inhibitors Programmed cell death protein 1 (PD-1...”
    Get full text
    Article
  8. 168
    Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block
    by Alisha Khan, Sana Riaz, Robert Carhart
    Published 2020-01-01
    “...Pembrolizumab is a monoclonal antibody directed towards programmed cell death protein 1 (PD-1...”
    Get full text
    Article
  9. 169
    Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future
    by Ece Esin
    Published 2017-01-01
    “... antigen 4, programmed cell death protein 1, and programmed cell death protein ligand 1 are the classes...”
    Get full text
    Article
  10. 170
    Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China
    by Si-Yang Liu, Yi-Long Wu
    Published 2017-07-01
    “... pathway using antibodies that inhibit programmed cell death protein 1 (PD-1) or programmed cell death...”
    Get full text
    Article
  11. 171
    Immunotherapy for pancreatic ductal adenocarcinoma: Challenges and opportunities
    by GE Weiyu, WANG Hongxia
    Published 2019-05-01
    “... for malignancies in recent years, immune checkpoint blockade focusing on programmed cell death protein 1 (PD-1...”
    Get full text
    Article
  12. 172
    Bacteria-mediated tumor immunotherapy via photothermally-programmed PD1 expression†
    View Fulltext in Publisher
    Article
  13. 173
    Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer
    “... in the treatment of superficial bladder cancer. Programmed cell death protein-1 (PD-1), cytotoxic T-lymphocyte...”
    Get full text
    Article
  14. 174
    Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab
    “... response to the anti-programmed cell death protein 1 (PD-1) antibody, nivolumab. This report suggests...”
    Get full text
    Article
  15. 175
    Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report
    by Li Shen, Haiyan Chen, Qichun Wei
    Published 2021-04-01
    “... administrated of anti-programmed cell death protein 1 (PD-1) antibody pembrolizumab. Although the patient...”
    Get full text
    Article
  16. 176
    Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma
    by Jingrong Lin, Minmin Xue, Mingyang Gao, Pu Yu, Shixin Han
    Published 2020-05-01
    “...Abstract Toripalimab is a monoclonal antibody targeting programmed cell death protein 1 (PD-1...”
    Get full text
    Article
  17. 177
    An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
    Get fulltext
    Article
  18. 178
    Research Progress of Adverse Events Related to PD-1/PD-L1 Inhibitors 
Based Combination Therapy
    by Xiaoyu GUO, Ti WEN, Xiujuan QU
    Published 2021-07-01
    “..., the characteristics of adverse events related to ICIs based combination therapies, especially programmed cell death...”
    Get full text
    Article
  19. 179
    Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
    “... through targeting programmed cell death protein-1 (PD-1) has demonstrated promising antitumor effects...”
    Get full text
    Article
  20. 180
    The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer
    “...The use of programmed cell-death protein 1 (PD-1)/programmed cell-death ligand 1 (PD-L1) inhibitors...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search